Fig. 2From: Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT studyCirculating endothelial progenitor cells CD45dimCD34+ VEGFR-2+. Results given as per 100 leukocytes. TG V1 treatment group pre-metformin, TG V2 treatment group post-metformin, SG V1 standard group pre observation, SG V2 standard group post 8 weeks observation. Line denotes in each box as median and + in each box denotes mean valueBack to article page